The pharmaceutical company makes drugs to treat HIV, psoriasis, rheumatiod arthritis, low testosterone, thyroid problems, and Parkinson’s.
News about AbbVie
If he pulls it off, he will make more than all of his peers combined.
A government watchdog will probe the orphan drug program.
After more than a year of public shaming.
Overall deal value declined last year.
He's tired of being a drug price hike scapegoat.